Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
142M
-
Number of holders
-
45
-
Total 13F shares, excl. options
-
4.99M
-
Shares change
-
+2.59M
-
Total reported value, excl. options
-
$136M
-
Value change
-
+$71.2M
-
Number of buys
-
41
-
Number of sells
-
-4
-
Price
-
$27.28
Significant Holders of Applied Therapeutics, Inc. - COMMON STOCK (APLT) as of Q4 2019
47 filings reported holding APLT - Applied Therapeutics, Inc. - COMMON STOCK as of Q4 2019.
Applied Therapeutics, Inc. - COMMON STOCK (APLT) has 45 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.99M shares
of 142M outstanding shares and own 3.53% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (987K shares), EMERALD MUTUAL FUND ADVISERS TRUST (633K shares), Knoll Capital Management, LP (467K shares), ALKEON CAPITAL MANAGEMENT LLC (440K shares), Perella Weinberg Partners Capital Management LP (401K shares), VANGUARD GROUP INC (340K shares), BlackRock Inc. (286K shares), FMR LLC (281K shares), Artisan Partners Limited Partnership (184K shares), and ACUTA CAPITAL PARTNERS, LLC (148K shares).
This table shows the top 45 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.